There remains a significant funding gap to support access to eye health services, but there is also a high return on investment due to lost productivity.
On the Vision Atlas, we review the data behind cost-effectiveness of treating cataracts and uncorrected refractive errors, and discuss optimising eye health funding.
This key report sheds light on the often-overlooked supply-side barriers that prevent many in low and middle-income countries (LMICs) from obtaining affordable, quality glasses.
(Opens in a new window)
The Lancet Global Health Commission on Global Eye Health gives us a key summary of funding sources, innovative financing and getting more eye health impact for the money. Best accessed on desktop.